Rheumatology

From Wikipedia, the free encyclopedia
(Redirected from Rheumatologists)
Jump to navigation Jump to search
Rheumatology
SystemMusculoskeletal, Immune
Significant diseasesAutoimmune disease inflammation, rheumatoid arthritis, lupus, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, gout, osteoporosis, polymyalgia rheumatica, giant cell arteritis,
Significant testsJoint aspirate, musculoskeletal exam, X-ray
SpecialistRheumatologist

Rheumatology (from Ancient Greek ῥεῦμα (rheûma) 'flowing current') is a branch of medicine devoted to the diagnosis and management of disorders of which the common feature is inflammation in the bones, muscles, joints, and internal organs.[1] Rheumatology covers more than 100 different complex diseases, collectively known as rheumatic diseases, which includes many forms of arthritis as well as lupus and Sjögren's syndrome.[1] Doctors who have undergone formal training in rheumatology are called rheumatologists.

Many of these diseases are now known to be disorders of the immune system, and rheumatology has significant overlap with immunology, the branch of medicine that studies the immune system.

Rheumatologist

[edit | edit source]
Rheumatologist
Occupation
NamesDoctor, Medical Specialist
Occupation type
Specialty
Activity sectors
Medicine
Specialty{{#statements:P1995}}
Description
Education required
Fields of
employment
Hospitals, Clinics

A rheumatologist is a physician who specializes in the field of medical sub-specialty called rheumatology. A rheumatologist holds a board certification after specialized training. In the United States, training in this field requires four years of undergraduate school, four years of medical school, and then three years of residency, followed by two or three years of additional Fellowship training. The requirements may vary in other countries. Rheumatologists are internists who are qualified by additional postgraduate training and experience in the diagnosis and treatment of arthritis and other diseases of the joints, muscles, and bones. Many rheumatologists also conduct research to determine the cause and better treatments for these disabling and sometimes fatal diseases. Treatment modalities are based on scientific research, currently, the practice of rheumatology is largely evidence-based.[2]

Rheumatologists treat arthritis, autoimmune diseases, pain disorders affecting joints, and osteoporosis.[3] There are more than 200 types of these diseases, including rheumatoid arthritis, osteoarthritis, gout, lupus, back pain, osteoporosis, and tendinitis. Some of these are very serious diseases that can be difficult to diagnose and treat. They treat soft tissue problems related to the musculoskeletal system and sports-related soft tissue disorders.

Pediatric rheumatologist: A pediatric rheumatologist is a pediatrician who specializes in the treatment of children with rheumatic disease.[4] Both specialties are important to address a child's milestone development and disease treatment throughout childhood. However, recognition of this sub-specialty has been slow, which has resulted in a global shortage of pediatric rheumatologists, and as a consequence, the demand for healthcare support far exceeds current service capacities.[5] Raising awareness of this is important to attract more upcoming pediatricians into this rewarding area of healthcare.

Diseases

[edit | edit source]

Diseases diagnosed or managed by rheumatologists include:

Degenerative arthropathies

[edit | edit source]

Inflammatory arthropathies

[edit | edit source]

Systemic conditions and connective tissue diseases

[edit | edit source]
File:Laserbehandling.jpg
Medical laser for the treatment of rheumatism.

Soft tissue rheumatism

[edit | edit source]

Local diseases and lesions affecting the joints and structures around the joints including tendons, ligaments capsules, bursae, stress fractures, muscles, nerve entrapment, vascular lesions, and ganglia. For example:

Diagnosis

[edit | edit source]
Synovial fluid examination[6][7]
Type WBC (per mm3) % neutrophils Viscosity Appearance
Normal <200 0 High Transparent
Osteoarthritis <5000 <25 High Clear yellow
Trauma <10,000 <50 Variable Bloody
Inflammatory 2,000–50,000 50–80 Low Cloudy yellow
Septic arthritis >50,000 >75 Low Cloudy yellow
Gonorrhea ~10,000 60 Low Cloudy yellow
Tuberculosis ~20,000 70 Low Cloudy yellow
Inflammatory: Arthritis, gout, rheumatoid arthritis, rheumatic fever

Physical examination

[edit | edit source]

Following are examples of methods of diagnosis able to be performed in a normal physical examination.

  • Schober's test tests the flexion of the lower back.
  • Multiple joint inspection
  • Musculoskeletal Examination
    • Screening Musculoskeletal Exam (SMSE) - a rapid assessment of structure and function
    • General Musculoskeletal Exam (GMSE) - a comprehensive assessment of joint inflammation
    • Regional Musculoskeletal Exam (RMSE) - focused assessments of structure, function and inflammation combined with special testing

Specialized

[edit | edit source]

Treatment

[edit | edit source]

Most rheumatic diseases are treated with analgesics, NSAIDs (nonsteroidal anti-inflammatory drug), steroids (in serious cases), DMARDs (disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept, and methotrexate for moderate to severe rheumatoid arthritis.[8] The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis.[9] Physiotherapy is vital in the treatment of many rheumatological disorders. Occupational therapy can help patients find alternative ways for common movements that would otherwise be restricted by their disease. Patients with rheumatoid arthritis often need a long term, coordinated and a multidisciplinary team approach towards management of individual patients. Treatment is often tailored according to the individual needs of each patient which is also dependent on the response and the tolerability of medications.

Beginning in the 2000s, the incorporation of biopharmaceuticals (which include inhibitors of TNF-alpha, certain interleukins, and the JAK-STAT signaling pathway) into standards of care is one of the paramount developments in modern rheumatology.[10]

Rheumasurgery

[edit | edit source]

Rheumasurgery (or rheumatoid surgery) is a subfield of orthopedics occupied with the surgical treatment of patients with rheumatic diseases.[11] The purpose of the interventions is to limit disease activity, soothe pain and improve function.[12]

Rheumasurgical interventions can be divided in two groups. The one is early synovectomies, that is the removal of the inflamed synovia in order to prevent spreading and stop destruction. The other group is the so-called corrective intervention, i.e. an intervention done after destruction has taken place.[13] Among the corrective interventions are joint replacements, removal of loose bone or cartilage fragments, and a variety of interventions aimed at repositioning and/or stabilizing joints,[14] such as arthrodesis.

Research directions

[edit | edit source]

Recently, a large body of scientific research deals with the background of autoimmune disease, the cause of many rheumatic disorders. Also, the field of osteoimmunology has emerged to further examine the interactions between the immune system, joints, and bones. Epidemiological studies and medication trials are also being conducted. The Rheumatology Research Foundation is the largest private funding source of rheumatology research and training in the United States.Lua error: Internal error: The interpreter exited with status 1.

History

[edit | edit source]

Rheumasurgery emerged in the cooperation of rheumatologists and orthopedic surgeons in Heinola, Finland, during the 1950s.[15]

In 1970 a Norwegian investigation estimated that at least 50% of patients with rheumatic symptoms needed rheumasurgery as an integrated part of their treatment.[16]

The European Rheumatoid Arthritis Surgical Society (ERASS) was founded in 1979.[17]

Around the turn of the 21st century, focus for treatment of patients with rheumatic disease shifted, and pharmacological treatment became dominant, while surgical interventions became rarer.[18][19]

References

[edit | edit source]
  1. ^ a b Lua error: Internal error: The interpreter exited with status 1.
  2. ^ Lua error: Internal error: The interpreter exited with status 1.
  3. ^ Lua error: Internal error: The interpreter exited with status 1.
  4. ^ Australian Rheumatology Association. (2024). What is a Paediatric Rheumatologist? Accessed 24 March 2024 from https://rheumatology.org.au/For-Patients/Your-Rheumatology-Healthcare-Team/What-is-a-Paediatric-Rheumatologist
  5. ^ Butler, S., Sculley, D., Santos, D. et al. Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies. Curr Rheumatol Rep (2024). https://doi.org/10.1007/s11926-024-01145-w
  6. ^ Lua error: Internal error: The interpreter exited with status 1.
  7. ^ Lua error: Internal error: The interpreter exited with status 1.
  8. ^ Lua error: Internal error: The interpreter exited with status 1.
  9. ^ Lua error: Internal error: The interpreter exited with status 1.
  10. ^ Lua error: Internal error: The interpreter exited with status 1.
  11. ^ "Norsk forening for revmakirurgi - Med hovedbase på Diakonhjemmet" LB Johannessen Tidsskr Nor Lægeforen 2004; 124:3110 Nr. 23 – 2. December 2004
  12. ^ Rheumakirurgi Lua error: Internal error: The interpreter exited with status 1.. Arne Skredderstuen November 2000
  13. ^ Den sykehusmessige revmatikeromsorgen i Norge (Kåss and Stene 1970), page 24.
  14. ^ "Surgery for Rheumatic Diseases" Lua error: Internal error: The interpreter exited with status 1. Cedars Sinai (http://www.cedars-sinai.edu)
  15. ^ Revmatisme: Gamle plager - ny viten (Munthe and Larsen 1987), page 49.
  16. ^ Den sykehusmessige revmatikeromsorgen i Norge (Kåss and Stene 1970), pages 24-25.
  17. ^ Rydholm, U "Reumakirurgiens uppgång, stabilisering og nedgång ur ett sydsvenskt perspektiv" 2013
  18. ^ Trender i revmakirurgisk behandling av pasienter med leddgikt og andre kronisk inflammatoriske leddsykdommer Lua error: Internal error: The interpreter exited with status 1., Norsk Rheumabulletin 4/2012, pages 16-17.
  19. ^ Lua error: Internal error: The interpreter exited with status 1.

Lua error: Internal error: The interpreter exited with status 1.

[edit | edit source]

Lua error: Internal error: The interpreter exited with status 1. Lua error: Internal error: The interpreter exited with status 1.